We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Edan Instruments

EDAN Instruments manufactures and distributes diagnostic medical equipments in the areas of obstetrics & gynecology, ... read more Featured Products: More products

Download Mobile App





Edan Debuts Next-Gen Blood Gas & Chemistry Analyzer and Patient Monitor at MEDICA 2021

By LabMedica International staff writers
Posted on 17 Nov 2021

EDAN Instruments, Inc. More...

(Shenzhen, China) introduced five new products that are aimed at improving caregiver efficacy and resource accessibility at MEDICA 2021.

Three ready-to-launch products from EDAN, namely its next-gen blood gas and chemistry analysis system i20, 3rd Generation patient monitor iX Series, and the integrated portable version biofeedback and stimulation system PA4 Pro made their debut at MEDICA 2021. EDAN also highlighted its recently-introduced paperless tablet ECG machine iSE and 5-part auto hematology analyzer H60s.

EDAN’s iSE series 12/18 lead ECG machine features an outstanding tablet design and is intended to bring exceptional mobile experience and build a seamless connection to IT systems. It is suitable for applications such as ambulance or first-aid, as well as modern paperless informationized hospitals. Weighing less than one kg, it can start sampling automatically once all lead cables are connected and the desired signal quality is achieved. Its innovative self-adaptive AC filter technology ensures more desirable ECG signal quality in real clinical settings, especially under extreme environments with unstable voltage.

"The products we present this time is mind-changing," said EDAN's Senior Director of Global Marketing and Strategic Operations, Alex You. "In healthcare, efficacy speaks volumes about how technologies make a positive impact on paramedics' workflow, and further save time for patient interaction and more. On iSE, you can have a glance at our plan in IoMT. Intelligent healthcare and IoT-enabled devices have been our focus in recent years. We believe med-tech can improve patient care, and IoT can make this one step further."

"EDAN remains committed to improving people's lives by providing value-driven, user-centered products. The needs are continually evolving. And that's our job to adapt to it and continually optimize our products for the market," added Hao Zhang, CEO of EDAN. "Our mission is to make caregivers' work easier so that they could do more for patients. And the product we present this time just speaks for it."

Related Links:
EDAN Instruments, Inc. 


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Shaking Incubator
Corning LSE 71L
New
Respiratory Syncytial Virus Test
OSOM® RSV Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.